Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 11 of 11

List	Outcome	Time frame	Description
Primary	Event-free survival	At maximum 3.5 years from study entry	As of 14th september 2010, all patients needed to evaluate the primary endpoint have been recruited.
Secondary	Rate of hematological complete remission	At maximum 60 days from induction therapy start
Secondary	Overall survival rate	At 2 years from study entry
Secondary	Rate of cumulative incidence of relapse	At 2 years from study entry
Secondary	Incidence of hematological and non-hematological toxicity episodes during treatment as assessed by CTC-NCI	At maximum 60 days from induction therapy start and at maximum 225 days from consolidation therapy start
Secondary	Rate of molecular remission after 3rd consolidation course	At maximum 225 days grom consolidation therapy start
Secondary	Assessment of acute promyelocytic leukemia/RARa transcript level reduction after induction and during consolidation therapy	At maximum 60 days from induction therapy start and at maximum 225 days from consolidation therapy start
Secondary	Quality of life at the end of induction therapy and at the end of the 3rd consolidation course	At maximum 60 days from induction therapy start and at maximum 225 days from consolidation therapy start
Secondary	Event free survival	At 2 years from study entry
Secondary	Total hospitalization days during study therapy	At maximum 3.5 years from study entry
Secondary	Event-free survival rate in the two arms	At 2 years from study entry

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00482833/registered